Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ION-859 by Ionis Pharmaceuticals for Parkinson's Disease: Likelihood of Approval
ION-859 is under clinical development by Ionis Pharmaceuticals and currently in Phase II for Parkinson's Disease. According to GlobalData, Phase...